SVU - International Journal of Medical Sciences, 2022 Background: Azithromycin is one of the most common drugs used in the protocol of treatment of pneumonia caused by COVID-19. But many researchers approved its toxicity on heart tissue.
Abeer F. Abd El-Naeem +2 more
doaj +1 more source
Azithromycin (Zithromax ®) [PDF]
Infectious Diseases in Obstetrics and Gynecology, 1996 Azithromycin (Zithromax ®, Pfizer, Inc., New York, NY) is a 15‐membered‐ring macrolide and the first azalide antibiotic. It is distinguished from other macrolides by its rapid and extensive penetration into intracellular and interstitial tissue compartments, accompanied by prolonged tissue and serum half‐lives.
openaire +2 more sources
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020.
PLoS ONE, 2022 BackgroundDuring the initial phase of the COVID-19 pandemic, there was great enthusiasm for the use of azithromycin with or without hydroxychloroquine.ObjectivesWe analyzed azithromycin consumption in Croatia in 2020 and compared this to the period 2017 ...
Nikolina Bogdanić +4 more
doaj +1 more source
Azithromycin Exhibits Activity Against Pseudomonas aeruginosa in Chronic Rat Lung Infection Model
Frontiers in Microbiology, 2021 Pseudomonas aeruginosa forms biofilms in the lungs of chronically infected cystic fibrosis patients, which are tolerant to both the treatment of antibiotics and the host immune system.
Manoj Kumar +11 more
doaj +1 more source
Australian Prescriber, 2015 Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and excellent tissue penetration. It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used in preference to other macrolides for some sexually transmitted and enteric infections.
Brendan J, McMullan, Mona, Mostaghim
openaire +2 more sources
Removal of azithromycin from wastewater using advanced oxidation processes (UV/H2O2) and moving-bed biofilm reactor (MBBR) by the response surface methodology (RSM) [PDF]
Journal of Advances in Environmental Health Research, 2019 Antibiotics are among the major concerns in terms of environmental control due to their cumulative properties, adverse health effects on humans, and development of drug resistance.
Rouhollah Shokri +4 more
doaj +1 more source
Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks
Infectious Diseases of Poverty, 2022 Background Mass drug administration (MDA) is a strategy to improve health at the population level through widespread delivery of medicine in a community.
Robert J. Rolfe +2 more
doaj +1 more source
The Concomitant Use of Azithromycin in Clinical Disease Management [PDF]
E3S Web of ConferencesAzithromycin, an extensively used second-generation macrolide antibiotic, has been prevalent in the management of a wide range of bacterial infections.
He Xinhang
doaj +1 more source
Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line
Journal of Microbiology, Immunology and Infection, 2019 Background: Cytokines and chemokines play critical roles in the pathogenesis of asthma. Azithromycin, a macrolides, is frequently used in asthmatic children with lower respiratory tract infection and is reported having anti-inflammatory and ...
Chang-Hung Kuo +4 more
doaj +1 more source
In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era. [PDF]
PLoS ONE, 2018 Recent WHO guidelines recommend dual therapy with ceftriaxone or cefixime plus azithromycin for gonorrhea. Azithromycin in combination with gentamicin or spectinomycin has been recommended in treatment failure cases.
Vikram Singh +4 more
doaj +1 more source